Status:
COMPLETED
The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy
Lead Sponsor:
Gruppo Italiano Studio Linfomi
Collaborating Sponsors:
Registro Tumori di Modena
Registro Tumori di Reggio Emilia
Conditions:
Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification
Eligibility:
All Genders
18+ years
Brief Summary
Positron Emission Tomography (PET) represents a step forward in the definition of response to therapy in patients with Hodgkin Lymphoma (HL). In particular the use of PET for the early assessment of r...
Eligibility Criteria
Inclusion
- Histologically confirmed classical Hodgkin lymphoma according to the current World Health Organisation Classification (nodular sclerosis, mixed cellularity, lymphocyte rich, lymphocyte depleted).
- Clinical stage I-IV.
- No previous chemotherapy, radiotherapy or other investigational drug for HL.
Exclusion
- 1\. None.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT01248000
Start Date
May 1 2009
End Date
May 1 2010
Last Update
November 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Registro Tumori di Modena
Modena, Modena, Italy, 41124